Log In
Print
BCIQ
Print
Print this Print this
 

ADC-1013

  Manage Alerts
Collapse Summary General Information
Company Alligator Bioscience AB
DescriptionAntibody-based CD40 receptor activator immunotherapy
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today